- Report
- December 2023
- 110 Pages
Global
From €4689EUR$4,799USD£3,914GBP
- Report
- October 2024
- 185 Pages
Global
From €3464EUR$3,545USD£2,892GBP
€3849EUR$3,939USD£3,213GBP
- Report
- March 2024
- 239 Pages
Global
From €5393EUR$5,713USD£4,350GBP
- Drug Pipelines
- June 2024
- 160 Pages
Global
From €2931EUR$3,000USD£2,447GBP
- Report
- January 2024
- 213 Pages
Global
From €4543EUR$4,650USD£3,793GBP
- Report
- April 2024
- 402 Pages
Global
From €4836EUR$4,950USD£4,038GBP
- Report
- October 2024
- 185 Pages
Global
From €3464EUR$3,545USD£2,892GBP
€3849EUR$3,939USD£3,213GBP
- Report
- October 2024
- 190 Pages
Global
From €3464EUR$3,545USD£2,892GBP
€3849EUR$3,939USD£3,213GBP
- Report
- October 2024
- 198 Pages
Global
From €3464EUR$3,545USD£2,892GBP
€3849EUR$3,939USD£3,213GBP
- Report
- October 2024
- 188 Pages
Global
From €3464EUR$3,545USD£2,892GBP
€3849EUR$3,939USD£3,213GBP
- Report
- October 2024
- 195 Pages
Global
From €3464EUR$3,545USD£2,892GBP
€3849EUR$3,939USD£3,213GBP
- Report
- October 2024
- 182 Pages
Global
From €3464EUR$3,545USD£2,892GBP
€3849EUR$3,939USD£3,213GBP
- Report
- October 2024
- 198 Pages
Global
From €3464EUR$3,545USD£2,892GBP
€3849EUR$3,939USD£3,213GBP
- Report
- October 2024
- 189 Pages
Global
From €3464EUR$3,545USD£2,892GBP
€3849EUR$3,939USD£3,213GBP
- Report
- October 2024
- 186 Pages
Global
From €3464EUR$3,545USD£2,892GBP
€3849EUR$3,939USD£3,213GBP
- Report
- October 2024
- 198 Pages
Global
From €3464EUR$3,545USD£2,892GBP
€3849EUR$3,939USD£3,213GBP
- Report
- October 2024
- 195 Pages
Global
From €3464EUR$3,545USD£2,892GBP
€3849EUR$3,939USD£3,213GBP
- Report
- October 2024
- 195 Pages
Global
From €3464EUR$3,545USD£2,892GBP
€3849EUR$3,939USD£3,213GBP
- Report
- October 2024
- 195 Pages
Global
From €3464EUR$3,545USD£2,892GBP
€3849EUR$3,939USD£3,213GBP
- Report
- October 2024
- 197 Pages
Global
From €3464EUR$3,545USD£2,892GBP
€3849EUR$3,939USD£3,213GBP
The Vaccines market is a sector of the pharmaceutical industry that focuses on the development, production, and distribution of vaccines. Vaccines are used to prevent and treat infectious diseases, and are an important part of public health initiatives. Vaccines are typically developed by pharmaceutical companies, and then approved by regulatory bodies such as the US Food and Drug Administration (FDA).
The Vaccines market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include Merck & Co., GlaxoSmithKline, Sanofi, Pfizer, and Johnson & Johnson. These companies are involved in the development, production, and distribution of a wide range of vaccines, including those for influenza, measles, mumps, rubella, and hepatitis. Smaller companies are also involved in the Vaccines market, such as Emergent BioSolutions and Bavarian Nordic. Show Less Read more